Bristol Myers Squibb to Fund Research for Five CSAM Students
Pharmaceutical company will support five health-focused research projects conducted by Montclair students
Posted in: Press Releases, Research, Science and Technology
A new agreement between Montclair State University and pharmaceutical company Bristol Myers Squibb (BMS) will help support the next generation of STEM scholars through exposure to and mentorship within the pharmaceutical industry.
The Princeton-based company granted the University $25,000 as part of the Bristol Myers Squibb Science Scholars Program, to be distributed among five different health-focused research projects led by students in the College of Science and Mathematics.
Each project will be assigned a mentor from BMS, who will offer support during the research process as well as discuss mentorship and career development opportunities for the student.
To qualify, student applicants must be an undergraduate or graduate student in a
STEM-related major (recommended majors include Chemistry, Biochemistry, Biology, Applied Mathematics or Computer Science), with a preferred minimum cumulative GPA of 3.0. Selected candidates will be notified in early April.
“This program allows students to participate in real world research projects alongside professional scientists, experiencing STEM careers first hand,” says College of Science and Mathematics Dean Lora Billings. “We are thankful that BMS supports our goal to increase quality experiential learning opportunities as we celebrate the courage, knowledge, and perseverance students draw on to thrive in STEM fields, diversifying the future STEM workforce.”
For more information on the College of Science and Mathematics, visit montclair.edu/csam.